Photodynamic therapy for conditions of the eye
    2.
    发明授权
    Photodynamic therapy for conditions of the eye 有权
    光动力治疗眼睛的状况

    公开(公告)号:US09226917B2

    公开(公告)日:2016-01-05

    申请号:US13140411

    申请日:2009-12-16

    摘要: The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodies such as bevacizumab or ranibizumab Photosensitizers may be selected from green porphyrins such as BPD-MA (verteporfin) and the photodynamic activation of the photo sensitizer may be accomplished using a reduced fluence rate. The use may further comprises an anti-inflammatory agent such as dexamethasone.

    摘要翻译: 描述了光动力学治疗和抗VEGF剂的组合在治疗特征为不想要的脉络膜新血管系统的病症中的用途。 这些病症包括湿性年龄相关性黄斑变性优选的抗VEGF剂是抗体,如贝伐珠单抗或雷珠单抗。光敏剂可以选自绿色卟啉如BPD-MA(维替泊芬),并且光敏剂的光动力学活化可以使用还原 注量率 使用可以进一步包含抗炎剂如地塞米松。

    System and method for correcting quality problems
    3.
    发明申请
    System and method for correcting quality problems 失效
    纠正质量问题的系统和方法

    公开(公告)号:US20050060057A1

    公开(公告)日:2005-03-17

    申请号:US10940127

    申请日:2004-09-13

    申请人: ShunXiong Wu Yong Hao

    发明人: ShunXiong Wu Yong Hao

    IPC分类号: G06F19/00

    摘要: A system for correcting quality problems includes a server (1), a database (2), and a plurality of client terminals (4) connected to the server through a network (3). The database stores data used or generated in utilizing the system. Each client terminal provides an interactive user interface for quality control operators to perform corrective actions. The server comprises: a data receiving module (12) for receiving confirmations and responses from the client terminals through the network; a data transmitting module (13) for transmitting initial corrective action reports generated by the server to corresponding client terminals, for operators located at the client terminals to reply to the initial corrective action reports; and a CAR (corrective action report) generating module (14) for integrating all data received by the data receiving module and automatically generating formal corrective action reports. A related method for correcting quality problems is also disclosed.

    摘要翻译: 用于校正质量问题的系统包括通过网络(3)连接到服务器的服务器(1),数据库(2)和多个客户终端(4)。 数据库存储利用系统中使用或生成的数据。 每个客户终端提供用于质量控制操作员执行校正动作的交互式用户界面。 该服务器包括:数据接收模块(12),用于通过网络从客户终端接收确认和响应; 数据发送模块(13),用于向位于客户终端的运营商发送由服务器生成的初始纠正措施报告给对应的客户终端,以回复初始纠正措施报告; 以及用于整合由数据接收模块接收的所有数据并自动生成正式校正动作报告的CAR(校正动作报告)生成模块(14)。 还公开了一种纠正质量问题的相关方法。

    ISOTHERMAL SYNTHESIS OF FUELS WITH REACTIVE OXIDES
    4.
    发明申请
    ISOTHERMAL SYNTHESIS OF FUELS WITH REACTIVE OXIDES 审中-公开
    燃料与反应性氧化物的同位素合成

    公开(公告)号:US20150030529A1

    公开(公告)日:2015-01-29

    申请号:US14128573

    申请日:2012-06-25

    摘要: A method for converting thermal energy to chemical energy by reducing a reactive oxide substrate at a constant temperature under a first atmosphere with a lower oxygen partial pressure, and then contacting the reduced oxide at the same temperature with a second atmosphere with a higher oxygen partial pressure, during which oxygen is driven into the reduced oxide by the oxygen chemical potential difference between the two atmospheres, thereby leaving fuel behind, i.e. producing fuel. A method for preparing the reactive oxide substrate by using liquid media as a binder and pore former and heating the mixture of the reactive oxide and the liquid media, thereby forming the reactive oxide substrate.

    摘要翻译: 一种通过在低氧分压的第一气氛下在恒定温度下还原反应性氧化物衬底然后在相同温度下与还原氧化物与较高氧分压的第二气氛接触来将热能转化为化学能的方法 在此期间,通过两个气氛之间的氧化学势差将氧气驱动到还原氧化物中,从而留下燃料,即产生燃料。 通过使用液体介质作为粘合剂和成孔剂来制备活性氧化物基材的方法,并加热反应性氧化物和液体介质的混合物,由此形成反应性氧化物基材。

    PHOTODYNAMIC THERAPY FOR CONDITIONS OF THE EYE
    5.
    发明申请
    PHOTODYNAMIC THERAPY FOR CONDITIONS OF THE EYE 有权
    眼睛条件的光化疗法

    公开(公告)号:US20120041356A1

    公开(公告)日:2012-02-16

    申请号:US13140411

    申请日:2009-12-16

    IPC分类号: A61M37/00

    摘要: The use of a combination of photodynamic therapy and an anti-VEGF agent in the treatment of conditions characterized by unwanted choroidal neovasculature is described. These conditions include wet age-related macular degeneration Preferred anti-VEGF agents are antibodies such as bevacizumab or ranibizumab Photosensitizers may be selected from green porphyrins such as BPD-MA (verteporfin) and the photodynamic activation of the photo sensitizer may be accomplished using a reduced fluence rate. The use may further comprises an anti-inflammatory agent such as dexamethasone.

    摘要翻译: 描述了光动力学治疗和抗VEGF剂的组合在治疗特征为不想要的脉络膜新血管系统的病症中的用途。 这些病症包括湿性年龄相关性黄斑变性优选的抗VEGF剂是抗体,如贝伐珠单抗或雷珠单抗。光敏剂可以选自绿色卟啉如BPD-MA(维替泊芬),并且光敏剂的光动力学活化可以使用还原 注量率 使用可以进一步包含抗炎剂如地塞米松。